Venus Medtech (Hangzhou) Inc. (HKG:2500)
5.62
0.00 (0.00%)
Jul 24, 2024, 4:00 AM HKT
Venus Medtech (Hangzhou) Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | - | -703.75 | -1,058 | -373.64 | -181.99 | Upgrade
|
Depreciation & Amortization | - | 119.53 | 108.36 | 48.76 | 36.01 | Upgrade
|
Other Amortization | - | 5.26 | 3.99 | 2.87 | 1.7 | Upgrade
|
Loss (Gain) From Sale of Assets | - | 1.27 | 0.13 | 0.15 | 0.56 | Upgrade
|
Asset Writedown & Restructuring Costs | - | 248.78 | 420.23 | 236.15 | - | Upgrade
|
Loss (Gain) From Sale of Investments | - | -21.29 | 0.19 | 0.66 | -1.31 | Upgrade
|
Loss (Gain) on Equity Investments | - | 12.38 | 13.94 | 11.71 | -0.57 | Upgrade
|
Stock-Based Compensation | - | - | - | - | 9 | Upgrade
|
Provision & Write-off of Bad Debts | - | -2.21 | 21.97 | 3.05 | -0.05 | Upgrade
|
Other Operating Activities | - | -152.55 | -98.26 | -239.77 | 39.47 | Upgrade
|
Change in Accounts Receivable | - | 14.21 | -7.85 | -74.13 | -68.76 | Upgrade
|
Change in Inventory | - | -26.18 | -13.68 | -29.18 | -37.63 | Upgrade
|
Change in Accounts Payable | - | 24.73 | 0.38 | 3.46 | 3.84 | Upgrade
|
Change in Unearned Revenue | - | 26.25 | -12.92 | 0.29 | -8.89 | Upgrade
|
Change in Other Net Operating Assets | - | -156.44 | -108.26 | -47.28 | -28.41 | Upgrade
|
Operating Cash Flow | - | -610.02 | -729.46 | -456.92 | -237.01 | Upgrade
|
Capital Expenditures | - | -260.64 | -169.98 | -82.07 | -49.78 | Upgrade
|
Sale of Property, Plant & Equipment | - | 2.91 | 9.41 | - | 0.03 | Upgrade
|
Cash Acquisitions | - | - | -813.49 | -124.59 | -54.61 | Upgrade
|
Divestitures | - | - | - | 22.5 | - | Upgrade
|
Sale (Purchase) of Intangibles | - | -2.27 | -8.79 | -19.71 | -74.27 | Upgrade
|
Investment in Securities | - | -18.77 | -98.17 | -416.78 | -109.82 | Upgrade
|
Other Investing Activities | - | -68.09 | 4.76 | 15 | - | Upgrade
|
Investing Cash Flow | - | -346.86 | -1,072 | -653.04 | -297.94 | Upgrade
|
Long-Term Debt Issued | - | 413.48 | 939.14 | - | - | Upgrade
|
Total Debt Issued | - | 413.48 | 939.14 | - | - | Upgrade
|
Long-Term Debt Repaid | - | -543.81 | -237.46 | -20.25 | -129.57 | Upgrade
|
Total Debt Repaid | - | -543.81 | -237.46 | -20.25 | -129.57 | Upgrade
|
Net Debt Issued (Repaid) | - | -130.34 | 701.68 | -20.25 | -129.57 | Upgrade
|
Issuance of Common Stock | - | - | - | 1,206 | 1,047 | Upgrade
|
Repurchase of Common Stock | - | - | - | -72.55 | - | Upgrade
|
Other Financing Activities | - | -43.65 | -66.55 | 278.31 | 10.37 | Upgrade
|
Financing Cash Flow | - | -173.99 | 635.14 | 1,391 | 927.75 | Upgrade
|
Foreign Exchange Rate Adjustments | - | 25.83 | 90.81 | -34.4 | -97.89 | Upgrade
|
Net Cash Flow | - | -1,105 | -1,076 | 247.04 | 294.92 | Upgrade
|
Free Cash Flow | - | -870.66 | -899.44 | -538.99 | -286.79 | Upgrade
|
Free Cash Flow Margin | - | -177.19% | -221.28% | -129.61% | -103.89% | Upgrade
|
Free Cash Flow Per Share | - | -1.99 | -2.05 | -1.23 | -0.70 | Upgrade
|
Cash Interest Paid | - | 61.69 | 43.81 | 1.96 | 2.33 | Upgrade
|
Cash Income Tax Paid | - | 3.44 | 3.07 | 8.65 | 5.47 | Upgrade
|
Levered Free Cash Flow | - | -717.14 | -559.42 | -268.15 | -396.39 | Upgrade
|
Unlevered Free Cash Flow | - | -677.94 | -531.53 | -266.96 | -395.04 | Upgrade
|
Change in Net Working Capital | -324.83 | 172.47 | 44.99 | 40.67 | 206.11 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.